Cargando…
Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis
BACKGROUND: Many app-based interventions targeting women with breast cancer have been developed and tested for effectiveness. However, information regarding the evaluation of the usage of these interventions is scarce. A better understanding of usage data is important to determine how women use apps...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527913/ https://www.ncbi.nlm.nih.gov/pubmed/32936087 http://dx.doi.org/10.2196/18896 |
_version_ | 1783589155550265344 |
---|---|
author | Zhu, Haihua Chen, Xiuwan Yang, Jinqiu Wu, Qiaoling Zhu, Jiemin Chan, Sally Wai-Chi |
author_facet | Zhu, Haihua Chen, Xiuwan Yang, Jinqiu Wu, Qiaoling Zhu, Jiemin Chan, Sally Wai-Chi |
author_sort | Zhu, Haihua |
collection | PubMed |
description | BACKGROUND: Many app-based interventions targeting women with breast cancer have been developed and tested for effectiveness. However, information regarding the evaluation of the usage of these interventions is scarce. A better understanding of usage data is important to determine how women use apps and how these interventions affect health outcomes. OBJECTIVE: This study aimed to examine the usage duration and login frequency of an app-based intervention, the Breast Cancer e-Support (BCS) program, and to investigate the association between usage data and participants’ demographic and medical characteristics. METHODS: This study is a secondary data analysis of a randomized controlled trial assessing the effectiveness of the BCS program. The BCS program contains four modules: Learning Forum, Discussion Forum, Ask-the-Expert Forum, and Your Story Forum. A total of 57 women in the intervention group accessed the BCS program during their 12-week chemotherapy. The app’s background system tracked the usage duration and login frequency for each forum and the entire BCS program. RESULTS: The total usage duration per participant ranged from 0 to 9371 minutes, and the login frequency per participant ranged from 0 to 774 times. The Discussion Forum and the Learning Forum were the most frequently used modules. The general linear model showed that age, education, family monthly income, and employment were associated with BCS usage duration and/or login frequency. Age (F(1,45)=10.09, P=.003, B=115.34, 95% CI 42.22-188.47) and education level (F(1,45)=7.22, P=.01, B=1949.63, 95% CI 487.76-3411.50) were positively associated with the usage duration of the entire BCS program. Family monthly income was positively associated with the usage duration of the Learning Forum (F(1,45)=11.85, P=.001, B=1488.55, 95% CI 617.58-2359.51) and the login frequency of the entire BCS program (F(1,45)=4.47, P=.04, B=113.68, 95% CI 5.33-222.03). Employment was negatively associated with the usage duration of the Ask-the-expert Forum (F(1,45)=4.50, P=.04, B=–971.87, 95% CI –1894.66 to –49.07) and the Your Story Forum (F(1,45)=5.36, P=.03, B=–640.71, 95% CI –1198.30 to –83.11) and positively associated with the login frequency of the entire BCS program (F(1,45)=10.86, P=.002, B=192.88, 95% CI 75.01-310.74). No statistical differences were found between BCS usage data and cancer stage, BMI, comorbidity, types of surgery, or cycles of chemotherapy. CONCLUSIONS: Overall, this study found considerable variability in the usage of app-based interventions. When health care professionals incorporate app-based interventions into their routine care for women with breast cancer, the learning and discussion functions of apps should be strengthened to promote engagement. Additionally, characteristics of women with breast cancer, such as age, level of education, income, and employment status, should be taken in consideration to develop tailored apps that address their particular needs and therefore improve their engagement with the app. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000639426; http://www.ANZCTR.org.au/ACTRN12616000639426.aspx |
format | Online Article Text |
id | pubmed-7527913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75279132020-10-15 Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis Zhu, Haihua Chen, Xiuwan Yang, Jinqiu Wu, Qiaoling Zhu, Jiemin Chan, Sally Wai-Chi JMIR Mhealth Uhealth Original Paper BACKGROUND: Many app-based interventions targeting women with breast cancer have been developed and tested for effectiveness. However, information regarding the evaluation of the usage of these interventions is scarce. A better understanding of usage data is important to determine how women use apps and how these interventions affect health outcomes. OBJECTIVE: This study aimed to examine the usage duration and login frequency of an app-based intervention, the Breast Cancer e-Support (BCS) program, and to investigate the association between usage data and participants’ demographic and medical characteristics. METHODS: This study is a secondary data analysis of a randomized controlled trial assessing the effectiveness of the BCS program. The BCS program contains four modules: Learning Forum, Discussion Forum, Ask-the-Expert Forum, and Your Story Forum. A total of 57 women in the intervention group accessed the BCS program during their 12-week chemotherapy. The app’s background system tracked the usage duration and login frequency for each forum and the entire BCS program. RESULTS: The total usage duration per participant ranged from 0 to 9371 minutes, and the login frequency per participant ranged from 0 to 774 times. The Discussion Forum and the Learning Forum were the most frequently used modules. The general linear model showed that age, education, family monthly income, and employment were associated with BCS usage duration and/or login frequency. Age (F(1,45)=10.09, P=.003, B=115.34, 95% CI 42.22-188.47) and education level (F(1,45)=7.22, P=.01, B=1949.63, 95% CI 487.76-3411.50) were positively associated with the usage duration of the entire BCS program. Family monthly income was positively associated with the usage duration of the Learning Forum (F(1,45)=11.85, P=.001, B=1488.55, 95% CI 617.58-2359.51) and the login frequency of the entire BCS program (F(1,45)=4.47, P=.04, B=113.68, 95% CI 5.33-222.03). Employment was negatively associated with the usage duration of the Ask-the-expert Forum (F(1,45)=4.50, P=.04, B=–971.87, 95% CI –1894.66 to –49.07) and the Your Story Forum (F(1,45)=5.36, P=.03, B=–640.71, 95% CI –1198.30 to –83.11) and positively associated with the login frequency of the entire BCS program (F(1,45)=10.86, P=.002, B=192.88, 95% CI 75.01-310.74). No statistical differences were found between BCS usage data and cancer stage, BMI, comorbidity, types of surgery, or cycles of chemotherapy. CONCLUSIONS: Overall, this study found considerable variability in the usage of app-based interventions. When health care professionals incorporate app-based interventions into their routine care for women with breast cancer, the learning and discussion functions of apps should be strengthened to promote engagement. Additionally, characteristics of women with breast cancer, such as age, level of education, income, and employment status, should be taken in consideration to develop tailored apps that address their particular needs and therefore improve their engagement with the app. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000639426; http://www.ANZCTR.org.au/ACTRN12616000639426.aspx JMIR Publications 2020-09-16 /pmc/articles/PMC7527913/ /pubmed/32936087 http://dx.doi.org/10.2196/18896 Text en ©Haihua Zhu, Xiuwan Chen, Jinqiu Yang, Qiaoling Wu, Jiemin Zhu, Sally Wai-Chi Chan. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 16.09.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Zhu, Haihua Chen, Xiuwan Yang, Jinqiu Wu, Qiaoling Zhu, Jiemin Chan, Sally Wai-Chi Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis |
title | Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis |
title_full | Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis |
title_fullStr | Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis |
title_full_unstemmed | Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis |
title_short | Mobile Breast Cancer e-Support Program for Chinese Women With Breast Cancer Undergoing Chemotherapy (Part 3): Secondary Data Analysis |
title_sort | mobile breast cancer e-support program for chinese women with breast cancer undergoing chemotherapy (part 3): secondary data analysis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527913/ https://www.ncbi.nlm.nih.gov/pubmed/32936087 http://dx.doi.org/10.2196/18896 |
work_keys_str_mv | AT zhuhaihua mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis AT chenxiuwan mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis AT yangjinqiu mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis AT wuqiaoling mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis AT zhujiemin mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis AT chansallywaichi mobilebreastcanceresupportprogramforchinesewomenwithbreastcancerundergoingchemotherapypart3secondarydataanalysis |